(Q35555376)
Statements
Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis (English)
van Roon EN
van de Laar MA
Janssen M
Keuper R
Houtman PM
2 September 2004
1 reference
1 reference